Circulating ACE2+ exosomes in plasma from both healthy donors and patients who recovered from COVID-19 inhibited SARS-CoV-2 infection by blocking the binding of the viral S protein to its cellular receptor (71). This evidence concerns the gene PROS1 and COVID-19.